IMCD N.V [IMCD] vs DSM-Firmenich AG [DSFIR] Detailed Stock Comparison

IMCD N.V

Euronext
Loading...

DSM-Firmenich AG

Euronext
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: IMCD N.V wins in 9 metrics, DSM-Firmenich AG wins in 10 metrics, with 0 ties. DSM-Firmenich AG appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricIMCD N.VDSM-Firmenich AGBetter
P/E Ratio (TTM)20.0827.46IMCD N.V
Price-to-Book Ratio2.740.92DSM-Firmenich AG
Debt-to-Equity Ratio87.6625.24DSM-Firmenich AG
PEG Ratio-0.2124.65IMCD N.V
EV/EBITDA12.7510.10DSM-Firmenich AG
Profit Margin (TTM)5.51%5.52%DSM-Firmenich AG
Operating Margin (TTM)9.06%12.07%DSM-Firmenich AG
EBITDA Margin (TTM)9.06%12.07%DSM-Firmenich AG
Return on Equity14.31%3.52%IMCD N.V
Return on Assets (TTM)6.01%2.18%IMCD N.V
Free Cash Flow (TTM)$252.76M$1.01BDSM-Firmenich AG
Dividend Yield1.91%2.63%DSM-Firmenich AG
1-Year Return-41.92%-39.32%DSM-Firmenich AG
Price-to-Sales Ratio (TTM)1.121.47IMCD N.V
Enterprise Value$6.96B$22.35BDSM-Firmenich AG
EV/Revenue Ratio1.441.72IMCD N.V
Revenue per Share (TTM)$83$49IMCD N.V
Earnings per Share (Diluted)$4.57$2.72IMCD N.V
Beta (Stock Volatility)1.001.00IMCD N.V
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

IMCD N.V vs DSM-Firmenich AG Stock Performance Analysis

Loading Price Chart...

IMCD N.V
DSM-Firmenich AG
IMCD N.V Stock Overview | DSM-Firmenich AG Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
IMCD N.V1.18%0.88%-4.12%-17.67%-28.45%-35.58%
DSM-Firmenich AG-1.33%-7.18%-12.95%-21.42%-19.30%-23.76%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
IMCD N.V-41.92%-25.15%-11.39%201.35%310.19%310.19%
DSM-Firmenich AG-39.32%-38.30%-38.30%-38.30%-38.30%-38.30%

News Based Sentiment: IMCD N.V vs DSM-Firmenich AG

IMCD N.V

News based Sentiment: MIXED

September presented a mixed bag for IMCD, with positive analyst ratings clashing with negative technical indicators and a declining stock price. While the company's fundamentals remain strong, the short-term outlook is uncertain, making it a complex investment requiring close monitoring, especially leading up to the November 6th trading update.

View IMCD N.V News Sentiment Analysis

DSM-Firmenich AG

News based Sentiment: NEGATIVE

September saw a concerning decline in DSM-Firmenich's stock price, hitting 52-week lows despite ongoing share repurchases and largely positive analyst ratings. While the company continues to invest in sustainability and preventative health, the market's negative reaction creates uncertainty and warrants careful monitoring.

View DSM-Firmenich AG News Sentiment Analysis

Performance & Financial Health Analysis: IMCD N.V vs DSM-Firmenich AG

MetricIMCDDSFIR
Market Information
Market Cap i€5.48B€19.96B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i281,979812,347
90 Day Avg. Volume i224,582525,917
Last Close€92.84€72.96
52 Week Range€90.20 - €159.00€72.96 - €124.85
% from 52W High-41.61%-41.56%
All-Time High€211.30 (Dec 06, 2021)€124.85 (Sep 30, 2024)
% from All-Time High-56.06%-41.56%
Growth Metrics
Quarterly Revenue Growth0.04%0.03%
Quarterly Earnings Growth-0.08%11.14%
Financial Health
Profit Margin (TTM) i0.06%0.06%
Operating Margin (TTM) i0.09%0.12%
Return on Equity (TTM) i0.14%0.04%
Debt to Equity (MRQ) i87.6625.24
Cash & Liquidity
Book Value per Share (MRQ)€33.46€81.03
Cash per Share (MRQ)€3.23€10.85
Operating Cash Flow (TTM) i€239.85M€1.59B
Levered Free Cash Flow (TTM) i€229.19M€921.50M
Dividends
Last 12-Month Dividend Yield i1.91%2.63%
Last 12-Month Dividend i€2.15€2.50

Valuation & Enterprise Metrics Analysis: IMCD N.V vs DSM-Firmenich AG

MetricIMCDDSFIR
Price Ratios
P/E Ratio (TTM) i20.0827.46
Forward P/E i13.5724.65
PEG Ratio i-0.2124.65
Price to Sales (TTM) i1.121.47
Price to Book (MRQ) i2.740.92
Market Capitalization
Market Capitalization i€5.48B€19.96B
Enterprise Value i€6.96B€22.35B
Enterprise Value Metrics
Enterprise to Revenue i1.441.72
Enterprise to EBITDA i12.7510.10
Risk & Other Metrics
Beta i1.001.00
Book Value per Share (MRQ) i€33.46€81.03

Financial Statements Comparison: IMCD N.V vs DSM-Firmenich AG

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)IMCDDSFIR
Revenue/Sales iN/AN/A
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) iN/AN/A
EBITDA iN/AN/A
Pre-Tax Income iN/AN/A
Income Tax iN/AN/A
Net Income (Profit) iN/AN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)IMCDDSFIR
Cash & Equivalents i€190.43M€2.82B
Total Current Assets i€1.86B€9.21B
Total Current Liabilities i€1.07B€3.42B
Long-Term Debt i€1.38B€5.18B
Total Shareholders Equity i€1.98B€21.51B
Retained Earnings i€915.55M€10.74B
Property, Plant & Equipment iN/AN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)IMCDDSFIR
Operating Cash Flow i€-1.95MN/A
Capital Expenditures i€128,000N/A
Free Cash Flow i€-8.92MN/A
Debt Repayment i€0N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricIMCDDSFIR
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i281,979812,347
Average Daily Volume (90 Day) i224,582525,917
Shares Outstanding i59.07M265.27M
Float Shares i55.45M247.17M
% Held by Insiders i0.02%0.10%
% Held by Institutions i0.75%0.32%

Dividend Analysis & Yield Comparison: IMCD N.V vs DSM-Firmenich AG

MetricIMCDDSFIR
Last 12-Month Dividend i€2.15€2.50
Last 12-Month Dividend Yield i1.91%2.63%
3-Year Avg Annual Dividend i€2.25€2.20
3-Year Avg Dividend Yield i1.71%2.22%
3-Year Total Dividends i€6.76€6.60
Ex-Dividend DateApr 29, 2025May 08, 2025